Prashant Rai

Prashant Rai

Auto-generated profile, based on publicly available information

Prashant Rai

Neurology, University of Texas Medical Branch, Galveston, USA

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2014 in Journal of Biomedical Informatics
Verified
Journal Article
Closed access
LCLicong Cui
Licong Cui
SSSatya S. Sahoo
Satya S. Sahoo
SLSamden D. Lhatoo
Samden D. Lhatoo
GGGaurav Garg
Gaurav Garg
PRPrashant Rai
Prashant Rai
GZGuo-Qiang Zhang
Guo-Qiang Zhang

1 February 2021 in Multiple Sclerosis and Related Disorders
Verified
Journal Article
Closed access
JVJoseph V. Villarreal
Joseph V. Villarreal
MAMaria J. Abraham
Maria J. Abraham
JAJoanne Allieza G. Acevedo
Joanne Allieza G. Acevedo
PRPrashant K. Rai
Prashant K. Rai
NTNeeharika Thottempudi
Neeharika Thottempudi
BGBhanu Gogia
Bhanu Gogia

31 August 2020 in Cureus
Verified
Journal Article
Open access
PDF file
BGBhanu Gogia
Bhanu Gogia
XFXiang Fang
Xiang Fang
PRPrashant Rai
Prashant Rai
Some of the reported neurological manifestations of COVID-19 are encephalopathy, headache, ischemic, hemorrhagic stroke, Miller Fisher syndrome, cranial neuropathies, and Guillain-Barre syndrome. We report a case of a 75-year-old COVID-19 patient with life-threatening intracranial hemorrhage. The initial labs on admission showed D-dimer of 1.04 µg/mL, which increased to 3.74 µg/mL the next day, PT/INR of 13.7 seconds/1.2, aPTT of 22 seconds, fibrinogen of 386 mg/dL, WBC of 9.71 K/µL, Hgb of 14.1 g/dL, platelet of 315 x 103/µL, LDH of 965 U/L, and CRP of 35.2 mg/dL. In addition to aspirin and Plavix (clopidogrel), the patient was started on a therapeutic dose of enoxaparin due to elevated D-dimer. A few days later, the patient had a change in the neurological examination. The CT of the head without contrast revealed a left-sided acute subdural hematoma, causing left to right midline shift, a large left temporal intraparenchymal, and subarachnoid hemorrhage with transtentorial herniation, leading to death. This case illustrates a combination of factors including hypertension, triple therapy (aspirin, clopidogrel, and enoxaparin), and underlying coagulopathy due to COVID-19, which contributed to the life-threatening intracranial hemorrhage in this patient. Therefore, this raises a concern about the safety of starting these patients preemptively on a therapeutic dose of anticoagulation.

20 May 2020 in Neuro-Oncology Practice
Verified
Journal Article
Open access
PDF file
BSBrian Stocksdale
Brian Stocksdale
SNSeema Nagpal
Seema Nagpal
JHJohn D Hixson
John D Hixson
DJDerek Richard Johnson
Derek Richard Johnson
PRPrashant Rai
Prashant Rai
ITIvo W Tremont-Lukats
Ivo W Tremont-Lukats
Patients with primary brain tumors often experience seizures, which can be the presenting symptom or occur for the first time at any point along the illness trajectory. In addition to causing morbidity, seizures negatively affect independence and quality of life in other ways, for example, by leading to loss of driving privileges. Long-term therapy with antiepileptic drugs (AEDs) is the standard of care in brain tumor patients with seizures, but the role of prophylactic AEDs in seizure-naive patients remains controversial. In this article, experts in the field discuss the issues of AED efficacy and toxicity, and explain their differing recommendations for routine use of prophylactic AEDs.

1 October 2019 in Epilepsy & Behavior
Verified
Journal Article
Closed access
BGBhanu Gogia
Bhanu Gogia
PRPrashant K. Rai
Prashant K. Rai
SMSamuel A. Matthys
Samuel A. Matthys
EMEric R. Mong
Eric R. Mong
RRRafael Rodriguez
Rafael Rodriguez
TMTodd Masel
Todd Masel

4 October 2021 in Cureus
Verified
Journal Article
Open access
BGBhanu Gogia
Bhanu Gogia
NTNeeharika Thottempudi
Neeharika Thottempudi
YAYousaf Ajam
Yousaf Ajam
ASAyush Singh
Ayush Singh
TGTamer Ghanayem
Tamer Ghanayem
PRPrashant Rai
Prashant Rai
The objective of this study is to report EEG findings in both COVID-19 survivors and non-survivors who underwent EEG either due to seizure or encephalopathy. Out of total 1468 COVID-19-positive patients, 19 patients underwent EEG. Eight out of 19 patients had a history of seizure disorder and in the remaining 11 with no prior history of seizures, four had a clinical seizure during their hospital stay. Only one had new-onset complex focal status epilepticus on EEG. Amongst the survivors (13/19), the most common EEG findings were normal followed by mild diffuse slowing. Amongst the non-survivors (6/19), the most common EEG finding was moderate to severe slowing in 50% of the patients. It can be deduced that COVID-19 infection does not increase the propensity of epileptiform discharges on EEG. There is perhaps a trend towards increased risk of new-onset status epilepticus in patients with encephalopathy and focal lesions.